Skip to main content
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in via AAO
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Current issue
Archive
Browse by collection
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Current issue
Archive
Browse by collection
Authors
About
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in via AAO
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 100, Issue 9
Phase IIb clinical trial of ranibizumab for the treatment of uveitic and idiopathic choroidal neovascular membranes
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
Clinical science
Phase IIb clinical trial of ranibizumab for the treatment of uveitic and idiopathic choroidal neovascular membranes
Online download statistics by month:
Online download statistics by month: December 2015 to August 2024
Abstract
Full
Pdf
Dec 2015
240
9
19
Jan 2016
106
6
47
Feb 2016
29
8
4
Mar 2016
25
4
4
Apr 2016
21
3
2
May 2016
35
5
8
Jun 2016
209
8
2
Jul 2016
19
0
1
Aug 2016
448
6
32
Sep 2016
456
3
25
Oct 2016
179
11
21
Nov 2016
122
3
10
Dec 2016
62
4
9
Jan 2017
75
0
5
Feb 2017
31
4
8
Mar 2017
35
13
11
Apr 2017
11
4
5
May 2017
26
4
4
Jun 2017
21
2
2
Jul 2017
36
10
10
Aug 2017
49
4
4
Sep 2017
150
4
4
Oct 2017
330
9
9
Nov 2017
117
19
9
Dec 2017
105
24
1
Jan 2018
71
21
5
Feb 2018
79
17
1
Mar 2018
47
13
1
Apr 2018
46
17
2
May 2018
67
14
2
Jun 2018
69
17
2
Jul 2018
66
29
4
Aug 2018
52
20
0
Sep 2018
45
25
0
Oct 2018
33
13
1
Nov 2018
27
11
0
Dec 2018
39
13
0
Jan 2019
25
13
0
Feb 2019
35
10
0
Mar 2019
19
1
1
Apr 2019
14
6
1
May 2019
23
13
1
Jun 2019
33
15
0
Jul 2019
42
15
0
Aug 2019
34
16
0
Sep 2019
31
15
0
Oct 2019
26
13
1
Nov 2019
44
13
0
Dec 2019
22
14
1
Jan 2020
23
12
0
Feb 2020
29
15
3
Mar 2020
25
13
3
Apr 2020
32
16
0
May 2020
30
20
2
Jun 2020
26
14
1
Jul 2020
41
13
1
Aug 2020
17
13
2
Sep 2020
51
13
0
Oct 2020
39
18
1
Nov 2020
20
0
0
Dec 2020
59
3
1
Jan 2021
7
1
1
Feb 2021
22
0
0
Mar 2021
33
1
1
Apr 2021
16
0
0
May 2021
3
1
0
Jul 2021
2
1
0
Aug 2021
1
0
0
Oct 2021
48
0
0
Nov 2021
12
0
0
Dec 2021
32
2
0
Jan 2022
26
4
1
Feb 2022
15
1
3
Mar 2022
27
1
0
Apr 2022
25
3
0
May 2022
40
0
0
Jun 2022
36
3
2
Jul 2022
35
1
0
Aug 2022
44
1
0
Sep 2022
48
1
1
Oct 2022
79
3
1
Nov 2022
24
0
2
Dec 2022
8
0
0
Jan 2023
21
1
1
Feb 2023
48
2
0
Mar 2023
4
0
0
Apr 2023
3
1
0
May 2023
8
0
0
Jun 2023
12
4
2
Jul 2023
20
2
1
Aug 2023
18
0
0
Sep 2023
15
1
1
Oct 2023
16
0
0
Nov 2023
28
0
0
Dec 2023
55
4
1
Jan 2024
14
0
0
Feb 2024
30
3
1
Mar 2024
9
1
1
Apr 2024
43
1
0
May 2024
37
5
4
Jun 2024
40
1
1
Jul 2024
25
0
0
Aug 2024
23
1
1
Total
5370
722
319
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in via AAO
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?